A study showed that berberine suppressed Hep3B and BEL-7404 cell proliferation by inhibiting glutamine uptake via suppressing SLC1A5 (a glutamine transporter) in vitro, and it could inhibit the tumor xenografts growth in vivo and reduce the expression of SLC1A5 [73]. This evidence concerns the gene SLC1A5 and neoplasm.